These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9922321)

  • 1. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma.
    Matsuda Y; Ichida T; Matsuzawa J; Sugimura K; Asakura H
    Gastroenterology; 1999 Feb; 116(2):394-400. PubMed ID: 9922321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
    Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
    World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the inactivation of p16 genes and the expression of P16 protein in primary hepatocellular carcinomas].
    Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):306-9. PubMed ID: 12545816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
    Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
    Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of methylation status of p16 tumor suppressor gene in soft tissue leiomyosarcoma].
    Xu J; Yang G; Bu H; Guo L; Zhang S; Liu J
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):16-8. PubMed ID: 11866950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16(INK4): involvement early and often in gastrointestinal malignancies.
    Herman JG
    Gastroenterology; 1999 Feb; 116(2):483-5. PubMed ID: 9922330
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression.
    Hui AM; Shi YZ; Li X; Takayama T; Makuuchi M
    Cancer Lett; 2000 Jun; 154(1):93-9. PubMed ID: 10799744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
    Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
    Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation.
    Pogribny IP; James SJ
    Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
    Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
    Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
    Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
    El-Naggar AK; Lai S; Clayman G; Lee JK; Luna MA; Goepfert H; Batsakis JG
    Am J Pathol; 1997 Dec; 151(6):1767-74. PubMed ID: 9403727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
    Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
    Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
    Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
    Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
    Matsuda Y
    World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.